The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 trial of cabozantinib in children and young adults with refractory sarcomas, Wilms tumor, and rare tumors: Children's Oncology Group Study (ADVL1622).
 
Srivandana Akshintala
No Relationships to Disclose
 
Brigitte C. Widemann
No Relationships to Disclose
 
Donald A. Barkauskas
Employment - Genentech (I)
Stock and Other Ownership Interests - Genentech (I)
Patents, Royalties, Other Intellectual Property - U.S. patent based on Ph.D. research in glioblastoma (I)
 
David Hall
No Relationships to Disclose
 
Joel M. Reid
No Relationships to Disclose
 
Stephan D. Voss
No Relationships to Disclose
 
AeRang Kim
No Relationships to Disclose
 
Elizabeth Fox
Other Relationship - Helsinn Therapeutics
 
Brenda Weigel
No Relationships to Disclose